Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01GCI
|
|||
| Drug Name |
PMID25776143-Compound-7
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Vantia Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H38Cl2N6O2
|
|||
| Canonical SMILES |
CC(C)(C)CCN1CCC(CC1)C(=O)NCC2=C(C=C(C=C2)C(=O)N3CC4=C(NC5=C3C=CC(=C5)Cl)N(N=C4)C)Cl
|
|||
| InChI |
1S/C31H38Cl2N6O2/c1-31(2,3)11-14-38-12-9-20(10-13-38)29(40)34-17-22-6-5-21(15-25(22)33)30(41)39-19-23-18-35-37(4)28(23)36-26-16-24(32)7-8-27(26)39/h5-8,15-16,18,20,36H,9-14,17,19H2,1-4H3,(H,34,40)
|
|||
| InChIKey |
QYCFYRDBJAXOJI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Vasopressin V1a receptor (V1AR) | Target Info | Antagonist | [1] |
| Target's Patent Info | Vasopressin V1a receptor (V1AR) | Target's Patent Info | [1] | |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Vascular smooth muscle contraction | ||||
| Reactome | Vasopressin-like receptors | |||
| G alpha (q) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Vasopressin V1a and V1b receptor modulators: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jun;25(6):711-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.